Following a shares in issue update for GlaxoSmithKline PLC (UK) resulting in a market capitalisation change greater than USD2bn, FTSE and Euronext announce the following changes: | INDEX | CHANGE | EFFECTIVE FROM START OF TRADING | | FTSEurofirst 100 Index | GlaxoSmithKline (UK 0925288) will remain in the index with a decreased shares in issue total of 5,240,433,283 and an unchanged investability weighting of 100%. | 31 July 2008 | | FTSEurofirst 300 Index | GlaxoSmithKline will be treated as above. | 31 July 2008 |
For index related enquiries or further information about FTSE please contact: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | Tel: +1 888 747 FTSE (3873) or +1 212 641 6165 | | Client Services in Asia Pacific: | Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811 |
Or, email your enquiries to info@ftseurofirst.com or visit our website at www.ftseurofirst.com |